Cargando…

Safety and efficacy of asciminib treatment in chronic myeloid leukemia patients in real-life clinical practice

Detalles Bibliográficos
Autores principales:	Garcia-Gutiérrez, Valentín, Luna, Alejandro, Alonso-Dominguez, Juan M., Estrada, Natalia, Boque, Concepcion, Xicoy, Blanca, Giraldo, Pilar, Angona, Anna, Alvarez-Larrán, Alberto, Sanchez-Guijo, Fermin, Ramírez, María José, Mora, Elvira, Vélez, Patricia, Rosell, Ana, Colorado Araujo, Mercedes, Cuevas, Beatriz, Sagüés, Miguel, Cortes, Montserrat, Encinas, Manuel Perez, Casado Montero, Luis Felipe, Moreno Vega, Melania, Serrano, Luis, Gomez, Valle, Garcia-Hernandez, Carmen, Lakhwani, Sunil, Paz Coll, Antonio, de Paz, Raquel, Suarez-Varela, Sara, Fernandez-Ruiz, Andrés, Perez Lopez, Raul, Ortiz-Fernández, Almudena, Jiménez-Velasco, Antonio, Steegmann-Olmedillas, Juan Luis, Hernández-Boluda, Juan Carlos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873237/ https://www.ncbi.nlm.nih.gov/pubmed/33563899 http://dx.doi.org/10.1038/s41408-021-00420-8

Ejemplares similares

Toxicity of Asciminib in Real Clinical Practice: Analysis of Side Effects and Cross-Toxicity with Tyrosine Kinase Inhibitors
por: Pérez-Lamas, Lucía, et al.
Publicado: (2023)

Real-life analysis on safety and efficacy of asciminib for ponatinib pretreated patients with chronic myeloid leukemia
por: Luna, A., et al.
Publicado: (2022)

Feasibility of treatment discontinuation in chronic myeloid leukemia in clinical practice: results from a nationwide series of 236 patients
por: Hernández-Boluda, Juan Carlos, et al.
Publicado: (2018)

Immediate Effects of Dasatinib on the Migration and Redistribution of Naïve and Memory Lymphocytes Associated With Lymphocytosis in Chronic Myeloid Leukemia Patients
por: Colom-Fernández, Beatriz, et al.
Publicado: (2019)

Impact of BCR-ABL1 Transcript Type on Response, Treatment-Free Remission Rate and Survival in Chronic Myeloid Leukemia Patients Treated with Imatinib
por: Marcé, Sílvia, et al.
Publicado: (2021)

Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis
por: Mosquera-Orgueira, Adrián, et al.
Publicado: (2022)

Inhibition of Xanthine Oxidoreductase Enhances the Potential of Tyrosine Kinase Inhibitors against Chronic Myeloid Leukemia
por: Romo-González, Marta, et al.
Publicado: (2020)

P680: PONATINIB 15 MG AS CONSOLIDATION PRIOR TO TREATMENT FREE REMISSION IN CHRONIC MYELOID LEUKEMIA
por: Garcia Gutierrez, Valentin, et al.
Publicado: (2023)

Asciminib for chronic myeloid leukaemia
Publicado: (2022)

S153: MECHANISMS OF TROMBOGENESIS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA UNDER TREATMENT WITH PONATINIB AND OTHER TYROSINE KINASE INHIBITORS
por: José Cuenca Zamora, Ernesto, et al.
Publicado: (2023)

Switching to second-generation tyrosine kinase inhibitor improves the response and outcome of frontline imatinib-treated patients with chronic myeloid leukemia with more than 10% of BCR-ABL/ABL ratio at 3 months
por: Casado, Luis-Felipe, et al.
Publicado: (2015)

Impact of Individual Comorbidities on Survival of Patients with Myelofibrosis
por: García-Fortes, María, et al.
Publicado: (2022)

Low-risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera
por: Triguero, Ana, et al.
Publicado: (2022)

Real‐world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea
por: Alvarez‐Larrán, Alberto, et al.
Publicado: (2022)

Should we move to a genomic classification of neutrophilic myeloid neoplasms?
por: Carreño-Tarragona, Gonzalo, et al.
Publicado: (2023)

Tyrosine Kinase Inhibitors Available for Chronic Myeloid Leukemia: Efficacy and Safety
por: García-Gutiérrez, Valentín, et al.
Publicado: (2019)

Current Treatment Options for Chronic Myeloid Leukemia Patients Failing Second-Generation Tyrosine Kinase Inhibitors
por: García-Gutiérrez, Valentín, et al.
Publicado: (2020)

Mechanisms of Resistance to the BCR-ABL1 Allosteric Inhibitor Asciminib
por: Qiang, Wang, et al.
Publicado: (2017)

Asciminib in chronic myeloid leukemia: a STAMP for expedited delivery?
por: Padala, Sandeep, et al.
Publicado: (2023)

SHP1 and SHP2 inhibition enhances the pro-differentiative effect of phorbol esters: an alternative approach against acute myeloid leukemia
por: Pérez-Fernández, Alejandro, et al.
Publicado: (2019)

Buildings’ Biaxial Tilt Assessment Using Inertial Wireless Sensors and a Parallel Training Model
por: Sánchez-Fernández, Luis Pastor, et al.
Publicado: (2023)

Application of IPSET-thrombosis in 1366 Patients Prospectively Followed From the Spanish Registry of Essential Thrombocythemia
por: Alvarez-Larrán, Alberto, et al.
Publicado: (2023)

Asciminib in chronic myeloid leukemia: many questions still remain to be answered
por: Eşkazan, Ahmet Emre
Publicado: (2021)

Asciminib Mitigates DNA Damage Stress Signaling Induced by Cyclophosphamide in the Ovary
por: Mattiello, Luca, et al.
Publicado: (2021)

Asciminib: the first-in-class allosteric inhibitor of BCR::ABL1 kinase
por: Choi, Eun-Ji
Publicado: (2023)

A Computer-Aided Detection System for Digital Chest Radiographs
por: Carrillo-de-Gea, Juan Manuel, et al.
Publicado: (2016)

Liquid Biopsy as Novel Tool in Precision Medicine: Origins, Properties, Identification and Clinical Perspective of Cancer’s Biomarkers
por: Fernández-Lázaro, Diego, et al.
Publicado: (2020)

Reproducibility and Applicability of Traditional Strength Training Prescription Recommendations
por: Heredia-Elvar, Juan Ramón, et al.
Publicado: (2022)

Influence of Telomere Length on the Achievement of Deep Molecular Response With Imatinib in Chronic Myeloid Leukemia Patients
por: Estrada, Natalia, et al.
Publicado: (2021)

A Computer Method for Pronation-Supination Assessment in Parkinson’s Disease Based on Latent Space Representations of Biomechanical Indicators
por: Sánchez-Fernández, Luis Pastor, et al.
Publicado: (2023)

PTPN13 and β-Catenin Regulate the Quiescence of Hematopoietic Stem Cells and Their Interaction with the Bone Marrow Niche
por: López-Ruano, Guillermo, et al.
Publicado: (2015)

A Novel RT-LAMP for the Detection of Different Genotypes of Crimean–Congo Haemorrhagic Fever Virus in Patients from Spain
por: Febrer-Sendra, Begoña, et al.
Publicado: (2023)

The Relationship between Vegetarian Diet and Sports Performance: A Systematic Review
por: Hernández-Lougedo, Juan, et al.
Publicado: (2023)

Genomic characterization of patients with polycythemia vera developing resistance to hydroxyurea
por: Alvarez-Larrán, Alberto, et al.
Publicado: (2020)

Relationship between morphological features and kinetic patterns of enhancement of the dynamic breast magnetic resonance imaging and clinico-pathological and biological factors in invasive breast cancer
por: Fernández-Guinea, Oscar, et al.
Publicado: (2010)

25-Hydroxyvitamin D Serum Levels Linked to Single Nucleotide Polymorphisms (SNPs) (rs2228570, rs2282679, rs10741657) in Skeletal Muscle Aging in Institutionalized Elderly Men Not Supplemented with Vitamin D
por: Fernández-Lázaro, Diego, et al.
Publicado: (2022)

El método de wald para la prueba de hipótesis de tipo secuencial
por: Colorado Hernández, José Luis
Publicado: (1989)

Diagnóstico para el modelo de regresión Logística : aspectos metodológicos
por: Colorado Hernández, José Luis
Publicado: (1994)

Clinical Perspective and Translational Oncology of Liquid Biopsy
por: Fernández-Lázaro, Diego, et al.
Publicado: (2020)

Allosteric enhancement of the BCR-Abl1 kinase inhibition activity of nilotinib by cobinding of asciminib
por: Oruganti, Baswanth, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gvkcrvhj57ck6anb05u8aljjq0